Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Cancer
|
October 26, 2005
Keynote speech: progress with a purpose
Andrew C von Eschenbach
Expert Opinion on Drug Safety
|
May 8, 2007
Eliminating error-prone notations in medical communications
Andrew C von Eschenbach
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
March 3, 2004
Andrew C. von Eschenbach, MD, director, National Cancer Institute
Andrew C von Eschenbach
Nature Reviews. Cancer
|
October 29, 2004
A vision for the National Cancer Program in the United States
Andrew C von Eschenbach
Journal of the National Medical Association
|
August 13, 2003
NCI sets goal of eliminating suffering and death due to cancer by 2015
Andrew C von Eschenbach
Food and Drug Law Journal
|
July 18, 2007
State of the FDA
Andrew C von Eschenbach
Food and Drug Law Journal
|
June 20, 2008
The FDA Amendments Act: reauthorization of the FDA
Andrew C von Eschenbach
The Oncologist
|
June 18, 2002
NCI remains committed to current mammography guidelines
Andrew C Von Eschenbach
Cancer Biology & Therapy
|
September 26, 2003
Introductory comments: models of anti-cancer therapy
Andrew C Von Eschenbach
FDA Consumer
|
March 15, 2006
The future of protecting and promoting public health
Andrew C von Eschenbach
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Cancer
|
October 26, 2005
Keynote speech: progress with a purpose
Andrew C von Eschenbach
Expert Opinion on Drug Safety
|
May 8, 2007
Eliminating error-prone notations in medical communications
Andrew C von Eschenbach
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
March 3, 2004
Andrew C. von Eschenbach, MD, director, National Cancer Institute
Andrew C von Eschenbach
Nature Reviews. Cancer
|
October 29, 2004
A vision for the National Cancer Program in the United States
Andrew C von Eschenbach
Journal of the National Medical Association
|
August 13, 2003
NCI sets goal of eliminating suffering and death due to cancer by 2015
Andrew C von Eschenbach
Food and Drug Law Journal
|
July 18, 2007
State of the FDA
Andrew C von Eschenbach
Food and Drug Law Journal
|
June 20, 2008
The FDA Amendments Act: reauthorization of the FDA
Andrew C von Eschenbach
The Oncologist
|
June 18, 2002
NCI remains committed to current mammography guidelines
Andrew C Von Eschenbach
Cancer Biology & Therapy
|
September 26, 2003
Introductory comments: models of anti-cancer therapy
Andrew C Von Eschenbach
FDA Consumer
|
March 15, 2006
The future of protecting and promoting public health
Andrew C von Eschenbach
Page
of 3